Lion dies in Ranchi Zoo
The 15-year-old big cat, a cross-breed between African and Asiatic lions, had a tumour in his stomach. This is the second death of a lion in the zoo within two months.
Shashank had been under continuous medical supervision for the past month because of his health complications. Zoo officials said it had been showing signs of weakness and reduced appetite for some time. He was brought from Bengaluru's Banarghatta National Park in 2014.
Birsa zoo vet Dr Om Prakash Sahu said the lion was undergoing treatment. "It gradually started avoiding food from the last few days and finally died on Thursday afternoon.
An autopsy examination revealed that the lion was suffering from a cancerous tumour in the stomach, resulting in its death. Samples of the tumour have been sent to the Ranchi Veterinary College for a pathological test and a detailed examination," Sahu added.
Ranchi: Shashank, a hybrid male lion inmate of the Bhagwan Birsa Biological Park in the city lost his long fight with cancer and succumbed to the tumour on Thursday, zoo authorities said.
The 15-year-old big cat, a cross-breed between African and Asiatic lions, had a tumour in his stomach. This is the second death of a lion in the zoo within two months.
Shashank had been under continuous medical supervision for the past month because of his health complications.
Zoo officials said it had been showing signs of weakness and reduced appetite for some time. He was brought from Bengaluru's Banarghatta National Park in 2014.
Birsa zoo vet Dr Om Prakash Sahu said the lion was undergoing treatment. "It gradually started avoiding food from the last few days and finally died on Thursday afternoon.
An autopsy examination revealed that the lion was suffering from a cancerous tumour in the stomach, resulting in its death. Samples of the tumour have been sent to the Ranchi Veterinary College for a pathological test and a detailed examination," Sahu added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
a day ago
- Hans India
Mpox deaths surpass 1,900 in Africa since 2024: Africa CDC
Addis Ababa: The death toll from Africa's ongoing mpox outbreak has surpassed 1,900 since the start of 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) said. During an online media briefing, Ngashi Ngongo, chief of staff and head of the Africa CDC's Executive Office, said that 27 mpox-affected African countries have reported 174,597 cases and 1,922 related deaths since the start of last year. "When we compare the data of last year and this year, we see that in 2025, we have already reported 94,300 cases that represent 117 per cent of the cases reported last year. On the confirmed cases, we have 29,084 (this year) compared to 19,713 (last year)," Ngongo said. He noted, however, that the continent has seen a steady decline in both confirmed and suspected cases in recent weeks, especially compared to the peak in May. Increased testing coverage was also highlighted as a positive sign in the fight against the disease, Xinhua news agency reported. Mpox, formerly known as monkeypox, was first detected in laboratory monkeys in 1958. It is a rare viral disease typically transmitted through body fluids, respiratory droplets, and contaminated materials. The infection often causes fever, rash, and swollen lymph nodes. The Africa CDC declared the outbreak a public health emergency of continental security in August 2024. The World Health Organization later designated it a public health emergency of international concern. Mpox spreads from person to person mainly through close contact with someone who has mpox, including members of a household. Close contact includes skin-to-skin and mouth-to-mouth or mouth-to-skin contact, and it can also include being face-to-face with someone who has mpox (such as talking or breathing close to one another, which can generate infectious respiratory particles). Mpox causes signs and symptoms which usually begin within a week but can start 1–21 days after exposure. Symptoms typically last 2–4 weeks but may last longer in someone with a weakened immune system. Mpox causes signs and symptoms which usually begin within a week but can start 1–21 days after exposure. Symptoms typically last 2–4 weeks but may last longer in someone with a weakened immune system.
Hans India
a day ago
- Hans India
WHO declares Kenya free of sleeping sickness
Nairobi: The World Health Organisation (WHO) certified Kenya as having eliminated human African trypanosomiasis, also known as sleeping sickness, as a public health challenge, making it the 10th country to reach this critical milestone. "I congratulate the government and people of Kenya on this landmark achievement," said WHO Director-General Tedros Adhanom Ghebreyesus in a statement issued in Nairobi, the Kenyan capital. "Kenya joins the growing ranks of countries freeing their populations of human African trypanosomiasis. This is another step toward making Africa free of neglected tropical diseases," Tedros added. Human African trypanosomiasis is the second neglected tropical disease to be eliminated in Kenya, following the country's certification as Guinea worm disease-free in 2018. The disease is caused by protozoan parasites transmitted by infected tsetse flies, according to the WHO. Symptoms include fever, headaches, joint pain, and, in advanced stages, neurological symptoms like confusion, disrupted sleep patterns, and behavioral changes. Aden Duale, Kenya's cabinet secretary for health, said the WHO validation of sleeping sickness elimination marked a historic step toward enhancing public health security in the country, fostering economic growth. Kenya detected the first case of sleeping sickness in the early 20th century and has since engaged in robust mitigation activities. The last two exported cases were detected in 2012 in the world-famous Maasai Mara National Reserve, Xinhua news agency reported. In recent years, the country has enhanced sleeping sickness surveillance in 12 health facilities across six historically endemic counties, which serve as sentinel sites. This effort is complemented by the use of modern diagnostic tools and the training of personnel to avert new transmission. Abdourahmane Diallo, the WHO representative in Kenya, said forward-looking leadership and partnerships were pivotal in accelerating progress toward sleeping sickness elimination in the East African country. Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease. It is caused by protozoans of the genus Trypanosoma, transmitted to humans by bites of tsetse flies (glossina) which have acquired the parasites from infected humans or animals. Tsetse flies inhabit sub-Saharan Africa and only certain species transmit the disease. Rural populations which depend on agriculture, fishing, animal husbandry or hunting are the most exposed. In many regions where tsetse flies are found, HAT is not. The disease has a focal distribution ranging from single villages to entire regions, and the incidence can vary from one village to the next.
New Indian Express
a day ago
- New Indian Express
Kenya has eliminated sleeping sickness, says WHO
GENEVA: Kenya has eliminated sleeping sickness as a public health problem, the World Health Organization announced on Friday, making it the 10th country to do so. The vector-borne disease, formally called human African trypanosomiasis, is endemic in sub-Saharan Africa. Without treatment, HAT is generally fatal, the WHO says. Sleeping sickness is transmitted to humans through the bites of tsetse flies that have acquired the the blood parasite Trypanosoma brucei from infected humans or animals. Rural populations dependent on agriculture, fishing, animal husbandry or hunting are deemed most at risk of exposure.
